Skinvisible Statistics
Total Valuation
Skinvisible has a market cap or net worth of 2.93 million. The enterprise value is 9.13 million.
| Market Cap | 2.93M |
| Enterprise Value | 9.13M |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Skinvisible has 4.89 million shares outstanding.
| Shares Outstanding | 4.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +2.20% |
| Owned by Insiders (%) | 3.90% |
| Owned by Institutions (%) | n/a |
| Float | 4.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 136.24 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.70 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -179.31% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 10,000 |
| Profits Per Employee | -592,565 |
| Employee Count | 2 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +777.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +777.57% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 45.48 |
| Average Volume (20 Days) | 1,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Skinvisible had revenue of 20,000 and -1.19 million in losses. Loss per share was -0.26.
| Revenue | 20,000 |
| Gross Profit | 20,000 |
| Operating Income | -515,525 |
| Pretax Income | -1.19M |
| Net Income | -1.19M |
| EBITDA | -496,787 |
| EBIT | -515,525 |
| Loss Per Share | -0.26 |
Balance Sheet
The company has 6,990 in cash and 6.20 million in debt, giving a net cash position of -6.19 million or -1.27 per share.
| Cash & Cash Equivalents | 6,990 |
| Total Debt | 6.20M |
| Net Cash | -6.19M |
| Net Cash Per Share | -1.27 |
| Equity (Book Value) | -9.58M |
| Book Value Per Share | -1.96 |
| Working Capital | -3.99M |
Cash Flow
| Operating Cash Flow | -49,041 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,577.63% |
| Pretax Margin | -5,925.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Skinvisible does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -43.56% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on January 4, 2019. It was a reverse split with a ratio of 0.02.
| Last Split Date | Jan 4, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
Skinvisible has an Altman Z-Score of -382.82. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -382.82 |
| Piotroski F-Score | n/a |